Madrigal Pharmaceuticals Statistics
Total Valuation
MDGL has a market cap or net worth of $6.28 billion. The enterprise value is $5.60 billion.
Important Dates
The last earnings date was Thursday, May 1, 2025, before market open.
| Earnings Date | May 1, 2025 |
| Ex-Dividend Date | n/a |
Share Statistics
MDGL has 22.20 million shares outstanding. The number of shares has increased by 13.87% in one year.
| Current Share Class | 22.20M |
| Shares Outstanding | 22.20M |
| Shares Change (YoY) | +13.87% |
| Shares Change (QoQ) | +0.74% |
| Owned by Insiders (%) | 14.62% |
| Owned by Institutions (%) | 66.73% |
| Float | 10.08M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 20.28 |
| Forward PS | 9.41 |
| PB Ratio | 9.22 |
| P/TBV Ratio | 8.96 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Financial Ratio HistoryEnterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | 17.64 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 5.91, with a Debt / Equity ratio of 0.17.
| Current Ratio | 5.91 |
| Quick Ratio | 5.41 |
| Debt / Equity | 0.17 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | -30.09 |
Financial Efficiency
Return on equity (ROE) is -50.16% and return on invested capital (ROIC) is -29.54%.
| Return on Equity (ROE) | -50.16% |
| Return on Assets (ROA) | -25.56% |
| Return on Invested Capital (ROIC) | -29.54% |
| Return on Capital Employed (ROCE) | -51.26% |
| Revenue Per Employee | $601,104 |
| Profits Per Employee | -$741,646 |
| Employee Count | 528 |
| Asset Turnover | 0.31 |
| Inventory Turnover | 0.38 |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has increased by +33.78% in the last 52 weeks. The beta is -0.92, so MDGL's price volatility has been lower than the market average.
| Beta (5Y) | -0.92 |
| 52-Week Price Change | +33.78% |
| 50-Day Moving Average | 321.39 |
| 200-Day Moving Average | 292.10 |
| Relative Strength Index (RSI) | 35.76 |
| Average Volume (20 Days) | 382,716 |
Short Selling Information
The latest short interest is 4.10 million, so 18.49% of the outstanding shares have been sold short.
| Short Interest | 4.10M |
| Short Previous Month | 4.03M |
| Short % of Shares Out | 18.49% |
| Short % of Float | 40.72% |
| Short Ratio (days to cover) | 11.54 |
Income Statement
In the last 12 months, MDGL had revenue of $317.38 million and -$391.59 million in losses. Loss per share was -$17.97.
| Revenue | 317.38M |
| Gross Profit | 306.64M |
| Operating Income | -425.15M |
| Pretax Income | -510.45M |
| Net Income | -391.59M |
| EBITDA | -423.84M |
| EBIT | -425.15M |
| Loss Per Share | -$17.97 |
Full Income StatementBalance Sheet
The company has $843.07 million in cash and $119.77 million in debt, giving a net cash position of $723.30 million or $32.58 per share.
| Cash & Cash Equivalents | 843.07M |
| Total Debt | 119.77M |
| Net Cash | 723.30M |
| Net Cash Per Share | $32.58 |
| Equity (Book Value) | 710.64M |
| Book Value Per Share | 32.03 |
| Working Capital | 820.74M |
Full Balance SheetCash Flow
In the last 12 months, operating cash flow was -$395.31 million and capital expenditures -$1.11 million, giving a free cash flow of -$396.41 million.
| Operating Cash Flow | -395.31M |
| Capital Expenditures | -1.11M |
| Free Cash Flow | -396.41M |
| FCF Per Share | -$17.85 |
Full Cash Flow StatementMargins
Gross margin is 96.61%, with operating and profit margins of -133.95% and -123.38%.
| Gross Margin | 96.61% |
| Operating Margin | -133.95% |
| Pretax Margin | -123.38% |
| Profit Margin | -123.38% |
| EBITDA Margin | -133.54% |
| EBIT Margin | -133.95% |
| FCF Margin | n/a |
Dividends & Yields
MDGL does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -13.87% |
| Shareholder Yield | -13.87% |
| Earnings Yield | -6.19% |
| FCF Yield | -6.27% |
Dividend DetailsAnalyst Forecast
The average price target for MDGL is $420.63, which is 48.79% higher than the current price. The consensus rating is "Strong Buy".
| Price Target | $420.63 |
| Price Target Difference | 48.79% |
| Analyst Consensus | Strong Buy |
| Analyst Count | 10 |
| Revenue Growth Forecast (5Y) | 83.01% |
| EPS Growth Forecast (5Y) | n/a |
Stock ForecastsStock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
MDGL has an Altman Z-Score of 9.76.
| Altman Z-Score | 9.76 |
| Piotroski F-Score | n/a |